Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients.

Shafi T, Powe NR, Meyer TW, Hwang S, Hai X, Melamed ML, Banerjee T, Coresh J, Hostetter TH.

J Am Soc Nephrol. 2017 Jan;28(1):321-331. doi: 10.1681/ASN.2016030374. Epub 2016 Jul 19.

2.

Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.

Kaysen GA, Johansen KL, Chertow GM, Dalrymple LS, Kornak J, Grimes B, Dwyer T, Chassy AW, Fiehn O.

J Ren Nutr. 2015 Jul;25(4):351-6. doi: 10.1053/j.jrn.2015.02.006. Epub 2015 Mar 19.

3.

Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.

Shafi T, Hostetter TH, Meyer TW, Hwang S, Hai X, Melamed ML, Banerjee T, Coresh J, Powe NR.

Am J Kidney Dis. 2017 Jul;70(1):48-58. doi: 10.1053/j.ajkd.2016.10.033. Epub 2017 Jan 12.

4.

Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.

Kim RB, Morse BL, Djurdjev O, Tang M, Muirhead N, Barrett B, Holmes DT, Madore F, Clase CM, Rigatto C, Levin A; CanPREDDICT Investigators.

Kidney Int. 2016 May;89(5):1144-1152. doi: 10.1016/j.kint.2016.01.014. Epub 2016 Mar 19.

PMID:
27083288
5.

Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.

Ottiger M, Nickler M, Steuer C, Bernasconi L, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Mueller B, Schuetz P.

Nutrition. 2018 Jan;45:135-141.e1. doi: 10.1016/j.nut.2017.07.001. Epub 2017 Jul 6.

PMID:
28870405
6.

Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study.

Mafune A, Iwamoto T, Tsutsumi Y, Nakashima A, Yamamoto I, Yokoyama K, Yokoo T, Urashima M.

Clin Exp Nephrol. 2016 Oct;20(5):731-739. Epub 2015 Dec 16.

7.

Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease.

Ottiger M, Nickler M, Steuer C, Odermatt J, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Mueller B, Schuetz P.

Eur J Intern Med. 2016 Dec;36:67-73. doi: 10.1016/j.ejim.2016.08.017. Epub 2016 Aug 24.

PMID:
27567042
8.

The Relationship Between Trimethylamine-N-Oxide and Prevalent Cardiovascular Disease in a Multiethnic Population Living in Canada.

Mente A, Chalcraft K, Ak H, Davis AD, Lonn E, Miller R, Potter MA, Yusuf S, Anand SS, McQueen MJ.

Can J Cardiol. 2015 Sep;31(9):1189-94. doi: 10.1016/j.cjca.2015.06.016. Epub 2015 Jun 25.

PMID:
26239008
9.

Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden.

Stubbs JR, House JA, Ocque AJ, Zhang S, Johnson C, Kimber C, Schmidt K, Gupta A, Wetmore JB, Nolin TD, Spertus JA, Yu AS.

J Am Soc Nephrol. 2016 Jan;27(1):305-13. doi: 10.1681/ASN.2014111063. Epub 2015 Jul 30.

10.

Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism.

Obeid R, Awwad HM, Rabagny Y, Graeber S, Herrmann W, Geisel J.

Am J Clin Nutr. 2016 Mar;103(3):703-11. doi: 10.3945/ajcn.115.121269. Epub 2016 Feb 10.

PMID:
26864355
11.

Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies.

Qi J, You T, Li J, Pan T, Xiang L, Han Y, Zhu L.

J Cell Mol Med. 2018 Jan;22(1):185-194. doi: 10.1111/jcmm.13307. Epub 2017 Aug 7.

12.

Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study.

Lever M, George PM, Slow S, Bellamy D, Young JM, Ho M, McEntyre CJ, Elmslie JL, Atkinson W, Molyneux SL, Troughton RW, Frampton CM, Richards AM, Chambers ST.

PLoS One. 2014 Dec 10;9(12):e114969. doi: 10.1371/journal.pone.0114969. eCollection 2014.

13.

Trimethylamine N-Oxide and Cardiovascular Outcomes in Patients with End-stage Kidney Disease Receiving Maintenance Hemodialysis.

Stubbs JR, Stedman MR, Liu S, Long J, Franchetti Y, West RE 3rd, Prokopienko AJ, Mahnken JD, Chertow GM, Nolin TD.

Clin J Am Soc Nephrol. 2019 Jan 21. pii: CJN.06190518. doi: 10.2215/CJN.06190518. [Epub ahead of print]

PMID:
30665924
14.

Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus.

Tang WH, Wang Z, Li XS, Fan Y, Li DS, Wu Y, Hazen SL.

Clin Chem. 2017 Jan;63(1):297-306. doi: 10.1373/clinchem.2016.263640. Epub 2016 Nov 18.

15.

Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies.

Heianza Y, Ma W, Manson JE, Rexrode KM, Qi L.

J Am Heart Assoc. 2017 Jun 29;6(7). pii: e004947. doi: 10.1161/JAHA.116.004947. Review.

16.

Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.

Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL.

N Engl J Med. 2013 Apr 25;368(17):1575-84. doi: 10.1056/NEJMoa1109400.

17.

Diabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels.

Dambrova M, Latkovskis G, Kuka J, Strele I, Konrade I, Grinberga S, Hartmane D, Pugovics O, Erglis A, Liepinsh E.

Exp Clin Endocrinol Diabetes. 2016 Apr;124(4):251-6. doi: 10.1055/s-0035-1569330. Epub 2016 Apr 28.

PMID:
27123785
18.

Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.

Schiattarella GG, Sannino A, Toscano E, Giugliano G, Gargiulo G, Franzone A, Trimarco B, Esposito G, Perrino C.

Eur Heart J. 2017 Oct 14;38(39):2948-2956. doi: 10.1093/eurheartj/ehx342. Review.

PMID:
29020409
19.

Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.

Wang Z, Tang WH, Buffa JA, Fu X, Britt EB, Koeth RA, Levison BS, Fan Y, Wu Y, Hazen SL.

Eur Heart J. 2014 Apr;35(14):904-10. doi: 10.1093/eurheartj/ehu002. Epub 2014 Feb 3.

20.

Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.

Trøseid M, Ueland T, Hov JR, Svardal A, Gregersen I, Dahl CP, Aakhus S, Gude E, Bjørndal B, Halvorsen B, Karlsen TH, Aukrust P, Gullestad L, Berge RK, Yndestad A.

J Intern Med. 2015 Jun;277(6):717-26. doi: 10.1111/joim.12328. Epub 2014 Dec 1.

Supplemental Content

Support Center